Natural and therapy-induced immunosurveillance in breast cancer
/in Breast Cancer, International Publications /von 2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-38Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2015-08-27 / 2016 Feb;5(2):e1078057Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
/in Breast Cancer, Dendritic Cells, International Publications /von 2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-7Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2015-06-02 / Front Immunol 2015;6:271Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
/in Breast Cancer, Hyperthermia, International Publications /von 2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-22Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
/in Breast Cancer, Hyperthermia, International Publications /von 2015-04-23 / Swiss Med Wkly 2015;145:w14133Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2015-04-18 / Breast 2015 Aug;24(4):418-25Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data
/in Breast Cancer, Hyperthermia, International Publications /von 2015-04-01 / Breast Care (Basel) 2015 Apr;10(2):109-16
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution